Inactive Instrument

Pharmagen Inc Share Price OTC Bulletin Board

Equities

End-of-day quote OTC Bulletin Board Other stock markets
- ^USD	-

2015	Pharmagen, Inc. cancelled the transaction announced on November 30, 2012	CI
2014	Pharmagen, Inc. Announces Management Changes	CI

Pharmagen, Inc. cancelled the transaction announced on November 30, 2012	29/11/15	CI
Pharmagen, Inc. Announces Management Changes	02/07/14	CI
Pharmagen, Inc. Announces Executive Changes	11/06/14	CI
Pharmagen, Inc. Appoints Russell Skibsted as Executive Vice President and Chief Financial Officer	11/06/14	CI
Pharmagen Appoints Additional Members to its Board of Directors	29/05/14	CI
Pharmagen Recruits Frederick W. Mundt as Senior Vice President of Sales	06/05/14	CI
Pharmagen, Inc. Appoints Boyd Relac as Chief Operating Officer	29/04/14	CI
Pharmagen, Inc. announced that it has received $0.5 million in funding	31/03/14	CI
Pharmagen, Inc. Appoints Richard A. Wolpow as Member of Board of Directors and Interim-Chief Operating Officer	24/02/14	CI
Pharmagen, Inc. announced that it has received $0.15 million in funding.	24/02/14	CI
Pharmagen, Inc. Appoints Richard A. Wolpow as Chairman of the Board of Directors and Interim Chief Operating Officer	17/12/13	CI
Pharmagen, Inc. announced that it expects to receive $0.5 million in funding	11/12/13	CI
Pharmagen, Inc. Announces Consolidated Earnings Results for the Third Quarter and Nine Months Ended September 30, 2013	14/11/13	CI
Pharmagen Seeks Acquisitions	31/10/13	CI
Pharmagen, Inc. announced that it has received $0.04 million in funding from Asher Enterprises, Inc.	09/08/13	CI